Construction usu.html

From 2010.igem.org

(Difference between revisions)
 
Line 32: Line 32:
=E. coli Protein Secretion System Construction=
=E. coli Protein Secretion System Construction=
-
In addition to our work developing the cyanobacterial toolkit, an effort was made to complete and further characterize portions of our 2009 project [http://2009.igem.org/Team:Utah_State] during this iGEM season.  USU’s 2009 iGEM team focused on simplifying cellular product recovery by developing a platform for protein secretion systems in the BioBricks format.
+
In addition to our work developing the cyanobacterial toolkit, an effort was made to complete and further characterize portions of [http://2009.igem.org/Team:Utah_State our 2009 project] during this iGEM season.  USU’s 2009 iGEM team focused on simplifying cellular product recovery by developing a platform for protein secretion systems in the BioBricks format.
==Overview==
==Overview==

Latest revision as of 00:00, 28 October 2010

USU_IGEM

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Construction

Contents

Cyanobacterial Toolkit Construction

Integration Plasmid Construction

The integration plasmid was constructed starting with pSB1A3 (Figure 1A). Four additional restriction sites (BamHI, XhoI, NdeI, and NheI) were added outside of the BioBrick docking sequence to allow recombination regions and Synechocystis-specific antibiotic resistance genes to be cloned in (Figure 1B). The two recombination regions (RS1 and RS2) where then cloned in flanking the BioBrick site, and a resistance gene (either Kanamycin resistance or Chloramphenicol resistance) was cloned in next to the BioBrick site (Figure 1C). An additional HindIII restriction site was added between the resistance gene and the RS1 region. This plasmid design allows for selection of the integrated BioBrick using the inserted resistance gene. These recombination regions and resistance genes can be easily exchanged for any desired region or resistance using restriction digest and ligations.

We decided to expand the current BioBrick plasmid naming convention for integration plasmids by adding the "_Int[Integrated Resistance][Species Abbreviation (include only if recombination regions are added)]" to the plasmid name. This provides the user with information on what resistance the cells with integrated BioBricks will have, and what species-specific recombination sites (if any) are part of the plasmid.


USU Plamid 1A.png USU Plamid 1B.png USU Plamid 1C.png

Figure 1. (A) The pSB1A3 plasmid which served as the starting point of construction. (B) Four restriction sites added surrounding the BioBrick site in pSB1A3. (C) Finished pSB1A3_IntC plasmid with recombination regions RS1 and RS2 and chloramphenicol resistance gene.


Promoter Construction

Using PCR, we amplified 15 native Synechocystis promoters and their native 5’ UTR and RBS regions from genomic DNA. Using oligonucleotide pairs, we created the 15 promoters alone (without their native 5’UTR and RBS), a standard native 5’UTR and RBS from Synechocystis, a consensus 5’UTR and RBS, and two secretion tags that function in Synechocystis, one native to the species and one artificially created.

Table 2. Primers used for PCR amplification from genomic DNA and oligonucleotide pairs. Four base pairs were added to the ends of the primers to increase digestion efficiency and equalize the Tm of the primer pairs. Green sequences are added BioBrick prefix and suffix sequences. Red bases are the bases mutated with site-directed mutagenesis.

USU Primer Table.PNG


E. coli Protein Secretion System Construction

In addition to our work developing the cyanobacterial toolkit, an effort was made to complete and further characterize portions of our 2009 project during this iGEM season. USU’s 2009 iGEM team focused on simplifying cellular product recovery by developing a platform for protein secretion systems in the BioBricks format.

Overview

Recovery costs of cellular products can account for as much as 80% of production expenses (Hearn and Acosta, 2001). In an attempt to reduce recovery costs, we developed a library of Silver fusion compatible gene constructs coding for secretion signal peptides. Five signal peptides commonly utilized in E. coli were converted to BioBrick format. Testing was performed by fusing signal peptides to the cycle 3 mutant of green fluorescent protein and the protein phasin. GFP was targeted as a model protein because of its ease of detection. Phasin is a protein coexpressed in organisms that produce polyhydroxyalkanoates (PHAs), a class of bioplastics. Phasin has been shown to interact and bind to PHA granules and to modify granule size (York, 2001; Maehara, 1999). Phasin targeted for secretion could produce a phasin-PHA complex, effectively transporting PHAs into the extracellular media. Transport of PHA into the media could reduce costs of bioplastic production and make this alternative plastic a more viable competitor to traditional petrochemically-derived plastics. At the time of last year’s jamboree, SDS-PAGE indicated that GFP and Phasin were both successfully released into the extracellular media when fused to the GeneIII signal peptide.

New Contributions

Two new secretion composite parts have been completed and submitted to the parts registry. These composite parts allowed us to test the functionality of the HlyA signal peptide. The newly created parts build on two parts submitted to the parts registry in 2009 (parts BBa_K208029, BBa_K208030). Most significantly, the proof of concept of the phasin/PHA-complex secretion was verified using the HlyA targeted phasin.


USU BBa K390501 Part.png

Fig 1: Parts BBa_K390501 and BBa_K390502 submitted to the parts registry.


Cells containing the genes necessary for PHA production, HlyBD membrane proteins, and the HlyA targeted phasin (BBa_K390501) were grown in M9 minimal media. Cells containing the genes for PHA production and the HlyBD membrane proteins were grown as a negative control. After 30 hours of growth, secreted PHA was isolated and analyzed using quantitative 1H NMR. Differences in intensity of the 1H NMR spectra indicate that PHA is released into the extracellular media when HlyA targeted phasin is expressed. We have reason to believe that this platform can be optimized to significantly reduce costs associated with commercial PHA production. This additional work further validates the parts created by USU’s 2009 team and the potential for their implementation in other cellular product recovery.

USU NMR spectra.png


Fig 2: 1H NMR spectra with PHA characteristic peaks amplified. The top spectrum reports PHA isolated gravimetrically from a culture containing HlyA targeted phasin. The bottom spectrum reports PHA in the negative control that is producing PHA but not secreting phasin. Notice the differences in peak intensities (y-axis).

References

Hearn MT, Acosta D (2001) Applications of novel affinity cassette methods: Use of peptide fusion handles for the purification of recombinant proteins. J Mol Recognit 14:323-369

Maehara A, Ueda S, Nakano H, Yamane T (1999) Analyses of a polyhydroxyalkanoic acid granule-associated 16-kilodalton protein and its putative regulator in the pha locus of Paracoccus denitrificans. J Bacteriol 191:2914-2921

York GM, Junker BH, Stubbe J, Sinskey AJ (2001) Accumulation of the PhaP Phasin of Ralstonia eutropha is dependent on production of polyhydroxybutyrate in cells. J Bacteriol 183:4217-4226